Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 413 clinical trials
Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.

/secondary AML who are in complete remission with positive measurable residual disease post-allogeneic hematopoietic stem cell transplantation (MRD+ post-aHSCT), can enhance the graft versus leukemia (GvL

blast cells
cell transplantation
remission
graft versus host disease
residual tumor
  • 0 views
  • 21 Apr, 2022
  • 7 locations
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

participants ≥ 55 years of age with Acute Myeloid Leukemia (AML) and in complete remission/complete remission with incomplete blood count recovery after conventional induction chemotherapy with or without

chronic myelomonocytic leukemia
remission
consolidation therapy
induction chemotherapy
consolidation chemotherapies
  • 0 views
  • 10 Apr, 2022
  • 2 locations
Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed AML

Tamibarotene is being studied as a treatment for participants with a type of leukemia called acute myeloid leukemia, or AML for short. Tamibarotene is being studied as a treatment for

acute promyelocytic leukemia
carbon monoxide
blast cells
ejection fraction
venetoclax
  • 0 views
  • 21 Apr, 2022
  • 8 locations
Study Evaluating the Safety of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

(r/r) acute myeloid leukemia (AML).

refractory acute myeloid leukemia (aml)
fludarabine
cyclophosphamide
ejection fraction
gilbert's syndrome
  • 0 views
  • 21 Apr, 2022
  • 7 locations
Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Acute myeloid leukemia (AML) is one of the most aggressive blood cancers, with a very low survival rate and few options for participants who are unable to undergo intensive chemotherapy, the

ejection fraction
venetoclax
carbon monoxide
azacitidine
  • 0 views
  • 29 Apr, 2022
Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia

The purpose of this study is to assess the safety, tolerability and clinical activity of the combination S64315 with azacitidine in patients with acute myeloid leukaemia.

azacitidine
  • 0 views
  • 30 Apr, 2022
  • 3 locations
Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML

The purpose of this study is to estimate the efficacy of immunotherapy with ex vivo expanded haploidentical NK cells as consolidation therapy for children/young adults with intermediate risk AML.

  • 0 views
  • 04 May, 2022
  • 1 location
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia

intermediate and high-risk acute myeloid leukemia(AML). The patients were randomly divided into azacitidine group and azacitidine combined with low-dose dasatinib group. The overall survival and disease-free

TP53
consolidation therapy
flow cytometry
ejection fraction
minimal residual disease
  • 1 views
  • 14 May, 2022
  • 1 location
Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML

In this prospective study, 30 newly untreated elderly patients with acute myeloid leukemia(AML) who were not suitable for standard chemotherapy were enrolled to observe the efficacy and side

cytarabine
remission
idarubicin
cladribine
venetoclax
  • 0 views
  • 09 May, 2022
  • 1 location
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

infusion after an allogeneic hematopoietic cell transplant (alloHCT) to treat patients with Acute Myeloid Leukemia (AML).

cell transplantation
minimal residual disease
residual tumor
blast cells
  • 0 views
  • 10 May, 2022
  • 1 location